# Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity

> **NCT01728792** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 80 (actual)

## Conditions studied

- Dengue Fever

## Interventions

- **BIOLOGICAL:** TDV

## Key facts

- **NCT ID:** NCT01728792
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-22
- **Primary completion:** 2013-11-01
- **Final completion:** 2013-11-21
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728792, "Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01728792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*